Updated on: 25 January 2024

Roles in:

1. In the past 36 months have you accepted the following from a commercial organisation with a financial interest in the broad topic area of the Group/Unit?

a) Support for attending meetings, including sabbaticals and study tours (this covers travel, accommodation and/or hospitality)?
No

b) Payment or honoraria for lectures, presentations, speaker bureaus, manuscript writing, or educational events?
No

c) Fees for organising education?
No

d) Grants and contracts?
No

e) Funds for a member of staff?
No

f) Fees for consulting?
No

g) Royalty or licences payments?
No

h) Payment for expert testimony?
No

i) Payment for a fellowship?
No

j) Payment for participation on a Data Safety Monitoring Board, Advisory Board, or Guideline Panel?
No

k) Payment for a leadership or other fiduciary role in other board, society, committee, or advocacy group?
No

2. In the past 36 months have you, your spouse/partner or an immediate family member been employed by or do you or they own a commercial organization with a financial interest in the broad topic area of the Group/Unit?
No

3. Do you own stocks or shares in a commercial organization with a financial interest in the broad topic area of the Group/Unit?
No

4. Do you hold any patents (planned, issued or pending) for products relevant to the broad topic area of the Group/Unit?
No

5. Do you have any other competing interests (financial or non-financial)?
Yes - Yes - I was the Deputy Managing Editor of Cochrane Pregnancy and Childbirth and employed by the University of Liverpool via NIHR Cochrane Infrastructure funding, paid to the host institution. Cochrane Pregnancy and Childbirth also received project funding from WHO to prepare Cochrane evidence to inform prioritised WHO recommendations for updating. I am a member of the Evidence Synthesis technical team for Updating WHO Maternal and Perinatal Health Recommendations (2019-2022) and I have, in the past, received travel and per diem expenses from WHO within the last three years in relation to attendance at WHO technical and prioritisation meetings.